Human Papilloma VirusNCT05175482
Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination
A study testing Virtual Education in people with Human Papilloma Virus and Health Behavior, run by Marmara University at 1 site in Turkey (Türkiye).
Trial summary
To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Human Papilloma Virus, Health Behavior
- What is being tested?
- Virtual Education
- Type of treatment
- Vaccines
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 127 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Dec 2021to 30 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- University students aged 18 years or over
Who cannot join
- University students have been received HPV vaccine
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination Among University Students: A Randomized Controlled Trial
To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students
Read the detailed description
In this randomized controlled study, it aims to evaluate impact of Health Belief Model based virtual education on Human Papilloma Virus Infection and Vaccination among University Students.
- Conditions
- Human Papilloma Virus, Health Behavior
- Being tested
- Virtual Education
- Medical subject headings
- Health Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual EducationOther
health belief model based virtual education
| Study group | Role | What they receive |
|---|---|---|
| Education received group | Experimental | Health belief model based education on HPV infection and vaccination Receives: Other: Virtual Education |
| Control Group | No intervention | No virtual education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first day
The scale consists of 10 items. A higher score represents a higher knowledge level.
Measured: baseline and next day after the education (at first day)
Change from baseline score of Human Papilloma Virus (HPV) Infection and Vaccination Health Belief Model Scale at first day
The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.
Measured: baseline and next day after the education (at first day)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jan 2022
- Study start30 Dec 2021
- Primary completion15 Jun 2022
- Study completion30 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Human Papilloma VirusStudies of the same condition, open and under way.
- More trials run by Marmara UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 127 participants (actual)
Sponsor and investigators
- Lead sponsor
- Marmara University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Betul Okuyan, Marmara University
- Investigators
- Betul Okuyan, Principal investigator, Marmara University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05175482
- Sponsor's protocol ID
- MARCPD-002
- Status last verified
- Oct 2022
- First submitted
- 12 Dec 2021
- Last updated
- 7 Oct 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Kavak S, Abdi A, Ay P, Sahin Y, Sancar M, Okuyan B. Short-term outcomes of health belief model-based brief virtual education on HPV infection and vaccination among pharmacy students: a randomized controlled trial. BMC Med Educ. 2026 Mar 12;26(1):645. doi: 10.1186/s12909-026-08986-2.
PubMed 41820928
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination Among University Students: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT05175482
- Acronym / sponsor ID
- MARCPD-002
- Conditions
- Human Papilloma Virus, Health Behavior
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 127 participants (actual)
- Lead sponsor
- Marmara UniversityUniversity, hospital or other
- Study start
- 30 Dec 2021 (actual)
- Primary completion
- 15 Jun 2022 (actual)
- Study completion
- 30 Sep 2022 (actual)
- First posted
- 3 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students
Detailed description
In this randomized controlled study, it aims to evaluate impact of Health Belief Model based virtual education on Human Papilloma Virus Infection and Vaccination among University Students.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Education received group | Experimental | Other: Virtual EducationHealth belief model based education on HPV infection and vaccination |
| Control Group | No intervention | –No virtual education |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- University students aged 18 years or over
Key exclusion criteria (1 listed)
- University students have been received HPV vaccine
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual Educationhealth belief model based virtual education | Other | Education received group |
Primary outcome
Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first day
Time frame: baseline and next day after the education (at first day)
The scale consists of 10 items. A higher score represents a higher knowledge level.
Change from baseline score of Human Papilloma Virus (HPV) Infection and Vaccination Health Belief Model Scale at first day
Time frame: baseline and next day after the education (at first day)
The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2022.
- Derived from this study: PubMed 41820928Kavak S, Abdi A, Ay P, Sahin Y, Sancar M, Okuyan B. Short-term outcomes of health belief model-based brief virtual education on HPV infection and vaccination among pharmacy students: a randomized controlled trial. BMC Med Educ. 2026 Mar 12;26(1):645. doi: 10.1186/s12909-026-08986-2.
Related trials for Human Papilloma Virus
Not yet recruitingPhase 1/2
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
Human Papillomavirus Infection
Active, not recruitingPhase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
RecruitingPhase 2
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection
RecruitingPhase 2
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Betul Okuyan principal investigator
Marmara University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual Education in people with Human Papilloma Virus and Health Behavior, run by Marmara University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first day (time frame: baseline and next day after the education (at first day)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05175482, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2022.